Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer
1 other identifier
observational
50
1 country
3
Brief Summary
The investigators propose to investigate the performance of the image reconstruction software with resolution recovery correction for bone SPECT studies. The investigators estimate that in only 30 minutes, using this new technique of collimator de-blurring, one could perform a fully 3-dimensional SPECT whole-body bone study, essentially obviating the necessity for doing planar bone studies. In the scope of the proposed project, the investigators group aims to test the hypothesis that one can perform a Tc-99m whole-body SPECT study in the same time as a regular routine planar bone study, with greater localization accuracy, and greater lesion detection. To establish a "gold standard" necessary to assess the performance of the SPECT bone scans, the investigators will compare number of malignant lesions detected in patients who are proven to have metastatic skeletal bone lesions on PET F-18 whole-body scans, with whole-body Tc-99m SPECT lesions. The investigators also propose to compare the detection of SPECT scans with standard planar bone scans. This will allow for two major comparisons (a) the accuracy of SPECT bone studies compared to planar bone studies, and (b) the accuracy of SPECT bone scans compared to F-18 PET studies. Most prior studies purporting to show the superiority of F-18 bone scans to Tc-99 bone scans were done only against either planar scans or a combination of planar scans and partial SPECT studies over the spine. We anticipate that F-18 bone scans, due to the higher counting statistics of PET agents, will show more lesions than SPECT, but the exact increase in sensitivity has never been compared to whole-body SPECT scans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2009
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 14, 2009
CompletedFirst Posted
Study publicly available on registry
January 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2016
CompletedMarch 3, 2017
March 1, 2017
7.6 years
January 14, 2009
March 1, 2017
Conditions
Keywords
Eligibility Criteria
Over the last 3-4 months, 60 anonymized patient studies were acquired using concurrent acquisition protocol with 20s, 15s, 10s, and 5s per view and with a total of 64 views (32 views/head). The data from these studies will be used to optimize the reconstruction process and establish the definitive reconstruction parameters to be used in the current study. We plan to accrue a total of 25 subjects with suspected bone metastases who will undergo planar bone scintigraphy, bone SPECT and a Na18F whole-body bone PET scan.
You may qualify if:
- Patients with a prior history of prostate cancer and
- clinically suspected bone metastases based on symptoms, radiological examinations or abnormal biochemistry results
You may not qualify if:
- Inability to consent to participate in the research study.
- Inability to lie supine for a period of at least 45 minutes.
- Inability to travel to the examination site to undergo the PET/CT examination.
- ECOG/WHO performance status ≥ 2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Lions Gate Hospital
North Vancouver, British Columbia, V7L 2L7, Canada
British Columbia Cancer Agency
Vancouver, British Columbia, V5Z 1L3, Canada
Vancouver Coastal Health Research Institute
Vancouver, British Columbia, V5Z 3P1, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Celler, PhD
University of British Columbia
- STUDY DIRECTOR
Philip Cohen
University of British Columbia
- STUDY DIRECTOR
Francois Benard
University of British Columbia
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 14, 2009
First Posted
January 16, 2009
Study Start
January 1, 2009
Primary Completion
August 10, 2016
Study Completion
August 10, 2016
Last Updated
March 3, 2017
Record last verified: 2017-03